GLP-1s in the news Hims & Hers sparked a major legal and regulatory battle when they announced a compounded pill version of Novo Nordisks weight-loss drug Wegovy, prompting Novo to accuse the telehealth firm of selling an unapproved and unsafe knockoff
In patients with facial fat grafting after weight loss , microfat may be considered for areas such as: Cheeks that have lost projection Temples that look hollow Selected areas of facial depletion Regions where volume loss affects facial balance I usually explain it this way: microfat is not meant to change the face into something different
After seven months, that patient went down to 222 pounds, and we've since reset his goal from 230 to 200 pounds
Heather Bell: honoraria, travel support or fees for advisory boards from Abbott, Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Menarini, Novo Nordisk, PCDS, Roche
One is another peptide
Current Opinion in Molecular Therapeutics